$Risk of fracture in patients with glucocorticoid requiring diseases$

Risk of fracture in patients with glucocorticoid requiring diseases

Bibliographic Details
Main Authors:	Giovanni Adami, Davide Gatti, Angelo Fassio, Alessandro Giollo, Ombretta Viapiana, Maurizio Rossini
Format:	Article
Language:	English
Published:	Elsevier 2021-04-01
Series:	Bone Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352187221000279

Similar Items

Association between environmental air pollution and rheumatoid arthritis flares
by: Giovanni Adami, et al.
Published: (2021-04-01)

Tapering glucocorticoids and risk of flare in rheumatoid arthritis on biological disease-modifying antirheumatic drugs (bDMARDs)
by: Giovanni Adami, et al.
Published: (2023-01-01)

The Emerging Roles of Endocrine Hormones in Different Arthritic Disorders
by: Eugenia Bertoldo, et al.
Published: (2021-05-01)

Factors associated with osteoporosis care of men: A real-life study on a nation-wide dataset
by: Giovanni Adami, et al.
Published: (2021-04-01)

Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis?
by: Giovanni Orsolini, et al.
Published: (2018-10-01)

Osteoporosis in Inflammatory Arthritides: New Perspective on Pathogenesis and Treatment
by: Denise Rotta, et al.
Published: (2020-12-01)

Correction to: Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis?
by: Giovanni Orsolini, et al.
Published: (2018-11-01)

Pharmacokinetics of Oral Cholecalciferol in Healthy Subjects with Vitamin D Deficiency: A Randomized Open-Label Study
by: Angelo Fassio, et al.
Published: (2020-05-01)

Factors associated with radiographic progression in rheumatoid arthritis starting biological diseases modifying anti-rheumatic drugs (bDMARDs)
by: Giovanni Adami, et al.
Published: (2023-09-01)

Comparable long-term retention rates and effects on bone mineral density of denosumab treatment in patients with osteoporosis with or without autoimmune inflammatory rheumatic diseases: real-life data
by: Angelo Fassio, et al.
Published: (2022-09-01)

Anti-CCP antibodies and bone
by: Giovanni Orsolini, et al.
Published: (2018-04-01)

Different fracture risk profile in patients treated with anti-osteoporotic drugs in real-life
by: G. Adami, et al.
Published: (2020-07-01)

Temporal trends and factors associated with vitamin D prescription and intake
by: Giovanni Adami, et al.
Published: (2021-04-01)

Disease Activity and Anticitrullinated Peptide Antibody Positivity Predict the Worsening of Ventricular Function in Rheumatoid Arthritis
by: Giovanni Cioffi, et al.
Published: (2020-04-01)

Machine learning to characterize bone biomarkers profile in rheumatoid arthritis
by: Giovanni Adami, et al.
Published: (2023-11-01)

Osteoporosis in 10 years time: a glimpse into the future of osteoporosis
by: Giovanni Adami, et al.
Published: (2022-03-01)

Pharmacodynamics of Oral Cholecalciferol in Healthy Individuals with Vitamin D Deficiency: A Randomized Open-Label Study
by: Angelo Fassio, et al.
Published: (2021-07-01)

Association between long-term exposure to air pollution and immune-mediated diseases: a population-based cohort study
by: Giovanni Adami, et al.
Published: (2022-03-01)

Real-life short-term effectiveness of anti-osteoporotic treatments: a longitudinal cohort study
by: Giovanni Adami, et al.
Published: (2022-06-01)

Higher body mass index is associated with a lower iloprost infusion rate tolerance and higher iloprost-related adverse events in patients with systemic sclerosis
by: Riccardo Bixio, et al.
Published: (2022-11-01)

Effects on Serum Inflammatory Cytokines of Cholecalciferol Supplementation in Healthy Subjects with Vitamin D Deficiency
by: Angelo Fassio, et al.
Published: (2022-11-01)

Changes in bone turnover markers and bone modulators during abatacept treatment
by: Giovanni Adami, et al.
Published: (2023-10-01)

Profile of bazedoxifene/conjugated estrogens for the treatment of estrogen deficiency symptoms and osteoporosis in women at risk of fracture
by: Rossini M, et al.
Published: (2013-07-01)

Duration of treatment for osteoporosis
by: Luca Idolazzi, et al.
Published: (2013-03-01)

Vitamin D and fractures: a sistematic review
by: L. Idolazzi, et al.
Published: (2011-09-01)

A case of mandible Paget’s disease of the bone treated with intravenous neridronate
by: A. Fassio, et al.
Published: (2016-12-01)

Vitamin D and disease severity in coronavirus disease 19 (COVID-19)
by: G. Adami, et al.
Published: (2021-01-01)

Effects of secukinumab on serum adipocytokines: preliminary data
by: A. Fassio, et al.
Published: (2017-09-01)

P169 RELATIONSHIP BETWEEN COMMON CAROTID DISTENSIBILITY/AORTIC STIFFNESS AND LEFT VENTRICULAR MORPHOLOGY AND FUNCTION IN RHEUMATOLOGIC PATIENTS
by: Michele Bevilacqua, et al.
Published: (2018-12-01)

Prevalence and incidence of osteoporotic fractures in patients on long-term glucocorticoid treatment for rheumatic diseases: the Glucocorticoid Induced OsTeoporosis TOol (GIOTTO) study
by: M. Rossini, et al.
Published: (2017-05-01)

Subclinical Myocardial Fibrosis in Systemic Lupus Erythematosus as Assessed by Pulse-Cancellation Echocardiography: A Pilot Study
by: Alessandro Giollo, et al.
Published: (2022-08-01)

Secukinumab retention rate is greater in patients with psoriatic arthritis presenting with axial involvement
by: G. Adami, et al.
Published: (2023-05-01)

Insight into the WNT system and its drug related response
by: S. Tamanini, et al.
Published: (2013-12-01)

Clinical development of neridronate: potential for new applications
by: Gatti D, et al.
Published: (2013-04-01)

Vitamin D and rheumatic diseases
by: M. Rossini, et al.
Published: (2014-07-01)

The negative bone effects of the disease and of chronic corticosteroid treatment in premenopausal women affected by rheumatoid arthritis
by: A. Fassio, et al.
Published: (2016-09-01)

Improvements in the management of rheumatic patients from vertebral image obtained through dual-energy X-ray absorptiometry
by: D. Gatti, et al.
Published: (2011-09-01)

Drug-induced osteonecrosis of the jaw: the state of the art
by: A. Fassio, et al.
Published: (2017-05-01)

CUMULATIVE RISKS OF FRACTURE IN PATIENTS USING ORAL GLUCOCORTICOIDS
by: Van Staa, T, et al.
Published: (2004)

Risk factors for hip fracture in elderly persons
by: P. Olivi, et al.
Published: (2011-06-01)